Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
Mimedx Group Inc (NASDAQ: MDXG) closed the day trading at $8.91 down -3.05% from the previous closing price of $9.19. In other words, the price has decreased by -$3.05 from its previous closing price. On the day, 0.8 million shares were traded. MDXG stock price reached its highest trading level at $9.33 during the session, while it also had its lowest trading level at $8.8.
Ratios:
For a better understanding of MDXG, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.60 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 23.69. For the most recent quarter (mrq), Quick Ratio is recorded 3.53 and its Current Ratio is at 4.10. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on July 02, 2024, initiated with a Overweight rating and assigned the stock a target price of $11.
On March 07, 2024, Lake Street started tracking the stock assigning a Buy rating and target price of $12.
On October 27, 2023, Craig Hallum started tracking the stock assigning a Buy rating and target price of $12.Craig Hallum initiated its Buy rating on October 27, 2023, with a $12 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 10 ’24 when GARDNER PHYLLIS bought 30,000 shares for $5.52 per share.
Hulse William Frank IV sold 20,381 shares of MDXG for $162,029 on Mar 13 ’24. The General Counsel and CAO now owns 479,959 shares after completing the transaction at $7.95 per share. On Feb 16 ’24, another insider, Whitlow Ricci S, who serves as the Chief Operating Officer of the company, sold 15,493 shares for $8.07 each. As a result, the insider received 125,075 and left with 416,321 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MDXG now has a Market Capitalization of 1350435200 and an Enterprise Value of 1239507712. As of this moment, Mimedx’s Price-to-Earnings (P/E) ratio for their current fiscal year is 15.23, and their Forward P/E ratio for the next fiscal year is 28.74. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.02. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.78 while its Price-to-Book (P/B) ratio in mrq is 7.23. Its current Enterprise Value per Revenue stands at 3.616 whereas that against EBITDA is 18.361.
Stock Price History:
The Beta on a monthly basis for MDXG is 1.96, which has changed by 0.1444583 over the last 52 weeks, in comparison to a change of 0.24933672 over the same period for the S&P500. Over the past 52 weeks, MDXG has reached a high of $10.14, while it has fallen to a 52-week low of $5.47. The 50-Day Moving Average of the stock is 3.95%, while the 200-Day Moving Average is calculated to be 23.77%.
Shares Statistics:
Over the past 3-months, MDXG traded about 775.22K shares per day on average, while over the past 10 days, MDXG traded about 613880 shares per day. A total of 146.96M shares are outstanding, with a floating share count of 115.68M. Insiders hold about 21.28% of the company’s shares, while institutions hold 47.90% stake in the company. Shares short for MDXG as of 1734048000 were 3852320 with a Short Ratio of 4.97, compared to 1731628800 on 3522533. Therefore, it implies a Short% of Shares Outstanding of 3852320 and a Short% of Float of 3.27.
